Monday, January 25, 2010
When Words Kill
The right to appeal of a patent applicant whose application is rejected persuant to a pre-grant opposition has been illusory at best. For a legal mind, it is unthinkable to envisage a situation where the first order becomes the final order. My article "How to destroy an invention - the patent office way" appeared in DNA Newspaper today. The same can be read in full at The Vanishing Point.
Thursday, January 21, 2010
Neither Here Nor There
Patent Agents are a unique breed. They are expected to know something about both law and science. As many gear up to take the patent agent examination on 23rd January 2010, here is a little piece titled "The Curious Case of Patent Agents" which appeared in today's The Hindu. The article raises certain questions on the current system of selecting patent agents based on a two paper examination followed by viva-voce. The full article can be read at The Vanishing Point.
Tuesday, January 19, 2010
Talk on Patents, Traditional Knowledge and the Pharmaceutical Industry
Graham Dutfield, Professor at the University of Leeds will be speaking at the Madras Law College (adjacent to Madras High Court) on "Patents, Traditional Knowledge and the Pharmaceutical Industry" on Thursday, 21st January, 2010 at 10:00 am. Those interested can assemble at the Law College campus by 9:45 am. I hope to be there too.
Labels:
patents,
pharmaceuticals,
traditional knowledge
Saturday, January 16, 2010
Pharma Patents is Moving to 'The Vanishing Point'
Pharma Patents blog is changing for the better. We are moving to a new blog, The Vanishing Point, a place like the point in perspective drawing where parallels appear to meet. The Vanishing Point Blog discusses issues at the intersection of law and technology. This will give us the room to discuss issues beyond patents and pharmaceuticals which affect technology-based enterprises. Some of the popular posts of pharma patents have been re-posted there. Please subscribe to The Vanishing Point here and continue to get email updates on pharmaceutical patents, law and technology issues and much more.
Subscribe to:
Posts (Atom)